New Results
Enhanced transmissibility, infectivity and immune resistance of the SARS-CoV-2 Omicron XBB.1.5 variant
Keiya Uriu, Jumpei Ito, Jiri Zahradnik, Shigeru Fujita, Yusuke Kosugi, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato
doi: https://doi.org/10.1101/2023.01.16.524178
Keiya Uriu
1Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Jumpei Ito
1Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Jiri Zahradnik
3Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
4First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia
Shigeru Fujita
1Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Yusuke Kosugi
1Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Gideon Schreiber
3Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
Kei Sato
1Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
5International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
6International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
7Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan
8Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan
9CREST, Japan Science and Technology Agency, Kawaguchi, Japan
Posted January 17, 2023.
Enhanced transmissibility, infectivity and immune resistance of the SARS-CoV-2 Omicron XBB.1.5 variant
Keiya Uriu, Jumpei Ito, Jiri Zahradnik, Shigeru Fujita, Yusuke Kosugi, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato
bioRxiv 2023.01.16.524178; doi: https://doi.org/10.1101/2023.01.16.524178
Enhanced transmissibility, infectivity and immune resistance of the SARS-CoV-2 Omicron XBB.1.5 variant
Keiya Uriu, Jumpei Ito, Jiri Zahradnik, Shigeru Fujita, Yusuke Kosugi, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato
bioRxiv 2023.01.16.524178; doi: https://doi.org/10.1101/2023.01.16.524178
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)